Last update Sept. 1, 2022
Very Low Risk
It is a phenylalkylamine calcium channel blocker and a class IV antiarrhythmic used in the treatment of angina, arrhythmia, and hypertension. Oral or intravenous administration in two to three daily doses.
It is excreted in breast milk in clinically non-significant amount (Anderson 1987, Miller1986, Inoue 1984, de Swiet 1984, Andersen 1983) and no problems have been observed in infants whose mothers were receiving this treatment. (Anderson 1987, Miller1986, Andersen 1983)
Plasma levels in these infants were undetectable or very low. (Anderson 1987, Miller1986, Andersen 1983)
Verapamil may induce to an increase of plasma Prolactin levels and galactorrhea. (Krysiak 2005, Kelley 1996, Fearrington 1983, Gluskin 1981)
Several medical societies and expert authors consider the use of this medication possible during breastfeeding. (Hale, LactMed, Malachias 2016, Briggs 2015, Schaefer 2015, Serrano 2015, Davanzo 2014, Rowe 2013, Jürgens 2009, Tan 2001, , de Swiet 1984). American Academy of Pediatrics: usually compatible with breastfeeding medication (AAP 2001). WHO List of Essential Medicines 2002: compatible with breastfeeding. (WHO 2002)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM